시장보고서
상품코드
1628885

감염성 창상 치료 관리 시장 : 제품 유형별, 치료 단계별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율, 예측(2024-2032년)

Infectious Wound Care Management Market, By Product Type, By Treatment Stage, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 346 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

감염성 창상 치료 관리 시장 규모는 2023년 15억 2,312만 달러로 2024년부터 2032년까지 2.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

감염성 창상 치료 관리 시장 역학

만성 질환의 유병률 상승으로 고급 감염성 창상 치료 관리 솔루션 수요 견인

감염성 창상 치료 관리 시장은 당뇨병과 같은 만성 질환의 유병률이 증가함에 따라 성장하고 있습니다. 당뇨병은 전 세계적으로 4억 6,000만명 이상이 앓고 있으며, 만성 상처와 감염의 위험을 높입니다. 미국 질병 예방관리센터(CDC)에 따르면 미국 인구의 10% 가까이 당뇨병을 앓고 있으며, 그 상당한 비율이 당뇨병성 발궤양을 발병하고 있기 때문에 전문적인 창상 치료 관리가 필요합니다. 세계 인구의 고령화에 따라 상처 치유를 복잡하게 하는 비만이나 혈관 질환 등의 증상을 가진 사람의 수도 증가하고 있습니다. 항균성 드레싱재, 생물학적 치료, 음압상처치료(NPWT) 등의 선진적인 창상 치료 제품은 이러한 감염을 효과적으로 관리하는데 필수적입니다. 게다가 센서 일체형 드레싱재 등의 스마트 창상 치료 솔루션의 기술 혁신이 진행되어, 보다 맞춤 치료 옵션이 제공되어, 만성 상처의 치료 시간이 단축되고 있습니다.

감염성 창상 치료 관리 시장 : 주요 고려사항

우리의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 2.5%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.

제품 유형별로 상처 드레싱은 2023년 최대 시장 점유율을 나타낼 것으로 예측됩니다.

치료 단계별로, 2023년에는 적극적인 감염 치료가 주요 유형이었습니다.

지역별로는 북미가 2023년에 주요 수익원이 됩니다.

감염성 창상 치료 관리 시장 : 세분화 분석

세계의 감염성 창상 치료 관리 시장은 제품 유형, 치료 단계, 최종 사용자 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 네 가지 범주로 나뉩니다. 상처 드레싱, 상처 세척제, 항균제, 상처 치유 장치입니다. 상처 피복재는 감염성 창상 치료 관리 및 치유 촉진에 중요한 역할을 하기 위해 시장을 선도하고 있습니다. 항균제는 감염 통제에 대응하고 그 뒤를 이었습니다. 상처 치료 기구는 인기를 끌고 있으며 상처 세정제는 필수적이지만 시장 규모는 작습니다.

시장은 치료 단계에 따라 세 가지 범주로 나뉩니다. 예방, 적극적인 감염 치료, 감염 후 관리가 있습니다. 적극적인 감염 치료는 상처 감염에 대처하는 데 매우 중요하기 때문에 우선합니다. 예방은 손상되기 쉬운 환자의 감염 위험을 완화하는 데 중점을 둡니다. 감염 후 관리는 감염 대책 후 치유와 재활에 필수적이지만 그 규모는 작습니다.

감염성 창상 치료 관리 시장 : 지역별 분석

감염성 창상 치료 관리 시장은 다양한 지역에서 다양한 성장을 보여줍니다. 북미, 특히 미국은 당뇨병과 같은 만성 질환의 유병률이 높고 창상 치료 솔루션의 요구가 높아지고 있기 때문에 큰 점유율을 차지하고 있습니다. 이 지역은 고급 의료 인프라, 정교한 창상 치료 제품에 대한 수요 증가, 고령화 인구 증가 등의 혜택을 누리고 있습니다. 독일, 프랑스, 영국 등의 국가에서는 만성 상처의 증례가 증가하고 있으며 감염성 창상 치료 관리에 대한 수요가 높아지고 있습니다. 아시아태평양은 특히 중국과 인도와 같은 당뇨병과 관련 상처 발생률이 상승하는 경향이 있는 국가에서 의료 접근성 개선으로 주요 시장으로 급부상하고 있습니다. 라틴아메리카와 중동, 아프리카도 의료 투자 증가와 창상 치료 솔루션에 대한 의식이 높아지면서 꾸준한 성장이 전망되고 있습니다.

감염성 창상 치료 관리 시장 : 경쟁 구도

감염성 창상 치료 관리 시장은 경쟁이 치열하며 대기업은 혁신적인 제품 개발과 전략적 제휴에 주력하고 있습니다. 주요 기업은 스미스 앤 네퓨, Molnlycke Health Care, Convatec, 3M 등이 있으며 항균 드레싱재, 음압상처치료(NPWT), 생물학적 상처치료 솔루션 등 폭넓은 선진 창상 치료제품을 제공합니다. Molnlycke의 Mepilex와 Smith &Nephew의 Allevyn은 시장에서 가장 많이 판매되는 제품 중 하나입니다. 현재 3M 산하에 있는 Acelity와 같은 신흥 기업은 NPWT 시스템과 같은 혁신적인 창상 치료 기술에 주력하고 있습니다. 바이오벤타스와 B. 브라운은 또한 중요한 선수이며, 첨단 생물학적 요법과 창상 치료 장비의 성장에 기여하고 있습니다. 대기업뿐만 아니라 소규모 전문 기업도 스마트 창상 치료 장비 및 재생 의료 솔루션과 같은 첨단 틈새 제품으로 시장에 진출하고 있습니다. 또한 기업들은 전략적 협업과 인수를 통해 신흥 시장에서의 입지를 확대하는 데 주력하고 있습니다

목차

제1장 감염성 창상 치료 관리 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 감염성 창상 치료 관리의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 감염성 창상 치료 관리 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 체제의 분석

제5장 감염성 창상 치료 관리 시장 : 지정학적 긴장 고조의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 감염성 창상 치료 관리 시장 상황

  • 감염성 창상 치료 관리 시장 점유율 분석(2023년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥기업의 분석

제7장 감염성 창상 치료 관리 시장 : 제품 유형별

  • 개요
    • 부문별 점유율 분석 : 제품 유형별
    • 상처 드레싱재
    • 상처 세정제
    • 항균제
    • 창상 치료 장치

제8장 감염성 창상 치료 관리 시장 : 치료 단계별

  • 개요
    • 부문별 점유율 분석 : 치료 단계별
    • 방지
    • 적극적인 감염 치료
    • 감염 후 관리

제9장 감염성 창상 치료 관리 시장 : 최종 사용자별

  • 개요
    • 부문별 점유율 분석 : 최종 사용자별
    • 병원
    • 클리닉
    • 외래수술센터(ASC)
    • 재택치료

제10장 감염성 창상 치료 관리 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 감염성 창상 치료 관리 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 프로파일
    • 3M Company
    • Acelity(KCI Licensing, Inc.)
    • Advanced BioHealing Inc.
    • Aspen Surgical Products
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Coloplast A/S
    • ConvaTec Group PLC
    • Derma Sciences, Inc.
    • Hollister Incorporated
    • Integra LifeSciences Corporation
    • Medline Industries, LP
    • Molnlycke Health Care AB
    • Organogenesis Inc.
    • Smith &Nephew plc
    • Stryker Corporation
    • Others

12장 AnalystView의 전방위 분석

KTH 25.02.11

REPORT HIGHLIGHT

Infectious Wound Care Management Market size was valued at USD 1,523.12 Million in 2023, expanding at a CAGR of 2.5% from 2024 to 2032.

The Infectious Wound Care Management Market focuses on treatments and products for managing wounds infected by bacteria, fungi, and other pathogens, aiming to promote healing and prevent complications. With an increasing number of surgical procedures and trauma-related injuries worldwide, the demand for effective wound care products is growing. The World Health Organization (WHO) estimates that approximately 2 million people worldwide suffer from chronic wounds each year, driving the need for advanced infectious wound care solutions. Rising cases of diabetes, obesity, and an ageing population are major contributors to chronic infections that complicate wound healing. However, challenges such as high treatment costs and limited reimbursement options can restrict market growth. Opportunities lie in the development of more effective antimicrobial dressings and biologic products, alongside the integration of advanced technologies like telemedicine and smart wound care systems, which offer faster, more personalized treatments. Increasing healthcare access in emerging markets also opens new avenues for growth.

Infectious Wound Care Management Market- Market Dynamics

Rising Prevalence of Chronic Conditions Drives Demand for Advanced Infectious Wound Care Management Solutions

The Infectious Wound Care Management Market is experiencing growth due to the rising prevalence of chronic conditions such as diabetes, which affects over 460 million people globally, increasing the risk of chronic wounds and infections. According to the Centers for Disease Control and Prevention (CDC), nearly 10% of the U.S. population suffers from diabetes, with a significant proportion developing diabetic foot ulcers, which require specialized wound care management. As the global population ages, the number of individuals with conditions like obesity and vascular diseases, which complicate wound healing, is also rising. Advanced wound care products, including antimicrobial dressings, biologic therapies, and negative pressure wound therapy (NPWT), are becoming essential for managing these infections effectively. Additionally, innovations in smart wound care solutions, such as sensor-integrated dressings, are gaining traction, offering more personalized treatment options and reducing healing time for chronic wounds.

Infectious Wound Care Management Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.5% over the forecast period (2024-2032)

Based on product type segmentation, Wound Dressings was predicted to show maximum market share in the year 2023

Based on Treatment Stage segmentation, Active Infection Treatment was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Infectious Wound Care Management Market- Segmentation Analysis:

The Global Infectious Wound Care Management Market is segmented based on Product Type, Treatment Stage, End-User, and Region.

The market is divided into four categories based on product type: Wound Dressings, Wound Cleansers, Antimicrobial Agents, and Wound Healing Devices. Wound Dressings lead the market due to their critical role in managing infectious wounds and promoting healing. Antimicrobial Agents follow closely, addressing infection control. Wound Healing Devices are gaining popularity, while Wound Cleansers are essential but occupy a smaller segment.

The market is divided into three categories based on Treatment Stage: Prevention, Active Infection Treatment, and Post-Infection Management. Active Infection Treatment takes priority, as it is crucial for addressing infections in wounds. Prevention follows, focusing on reducing infection risks in vulnerable patients. Post-infection management is essential for healing and rehabilitation after infection control, but it is a smaller segment.

Infectious Wound Care Management Market- Geographical Insights

The Infectious Wound Care Management Market exhibits varied growth across different regions. North America, particularly the United States, holds a significant share due to a high prevalence of chronic diseases such as diabetes, which leads to an increased need for wound care solutions. The region benefits from advanced healthcare infrastructure, increasing demand for sophisticated wound care products, and a growing ageing population. Europe follows closely, with countries like Germany, France, and the UK witnessing rising cases of chronic wounds, boosting the demand for infectious wound care management. The Asia-Pacific region is rapidly emerging as a key market, driven by improvements in healthcare access, particularly in countries like China and India, where the incidence of diabetes and related wounds is on the rise. Latin America and Middle East & Africa are also expected to see steady growth, supported by increasing healthcare investments and a growing awareness of wound care solutions.

Infectious Wound Care Management Market- Competitive Landscape:

The Infectious Wound Care Management Market is highly competitive, with leading players focusing on innovative product development and strategic partnerships. Key companies include Smith & Nephew, Molnlycke Health Care, Convatec, and 3M, which offer a wide range of advanced wound care products, including antimicrobial dressings, negative pressure wound therapy (NPWT), and biologic wound care solutions. Molnlycke's Mepilex and Smith & Nephew's Allevyn are among the top-selling products in the market. Newer players like Acelity, now part of 3M, focus on innovative wound-healing technologies, such as NPWT systems. Bioventus and B. Braun are also significant players, contributing to the growth of advanced biological therapies and wound care devices. In addition to large companies, smaller, specialized firms are entering the market with advanced, niche products like smart wound care devices and regenerative medicine solutions. Companies are also focusing on expanding their presence in emerging markets through strategic collaborations and acquisitions.

Recent Developments:

In September 2024, HCAH partnered with Aroa Biosurgery to launch a wound care initiative focused on preventing and treating bedsores. The "WOW Nurses" program emphasizes specialized training for nurses to enhance recovery and reduce complications associated with infectious wounds.

In October 2024, Molnlycke Health Care announced a research collaboration with Transdiagen to enhance infectious wound care management. This partnership aims to utilize novel wound gene signatures for developing innovative treatments, improving understanding and outcomes in chronic wound healing and tissue regeneration.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M Company
  • Acelity (KCI Licensing, Inc.)
  • Advanced BioHealing Inc.
  • Aspen Surgical Products
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Coloplast A/S
  • ConvaTec Group PLC
  • Derma Sciences, Inc.
  • Hollister Incorporated
  • Integra LifeSciences Corporation
  • Medline Industries, LP
  • Molnlycke Health Care AB
  • Organogenesis Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Others

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Wound Dressings
  • Wound Cleansers
  • Antimicrobial Agents
  • Wound Healing Devices

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET, BY TREATMENT STAGE- MARKET ANALYSIS, 2019 - 2032

  • Prevention
  • Active Infection Treatment
  • Post-Infection Management

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Home Healthcare

GLOBAL INFECTIOUS WOUND CARE MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Infectious Wound Care Management Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Infectious Wound Care Management Market Snippet by Product Type
    • 2.1.2. Infectious Wound Care Management Market Snippet by Treatment Stage
    • 2.1.3. Infectious Wound Care Management Market Snippet by End-User
    • 2.1.4. Infectious Wound Care Management Market Snippet by Country
    • 2.1.5. Infectious Wound Care Management Market Snippet by Region
  • 2.2. Competitive Insights

3. Infectious Wound Care Management Key Market Trends

  • 3.1. Infectious Wound Care Management Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Infectious Wound Care Management Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Infectious Wound Care Management Market Opportunities
  • 3.4. Infectious Wound Care Management Market Future Trends

4. Infectious Wound Care Management Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Infectious Wound Care Management Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Infectious Wound Care Management Market Landscape

  • 6.1. Infectious Wound Care Management Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Infectious Wound Care Management Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Wound Dressings
    • 7.1.3. Wound Cleansers
    • 7.1.4. Antimicrobial Agents
    • 7.1.5. Wound Healing Devices

8. Infectious Wound Care Management Market - By Treatment Stage

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment Stage, 2023 & 2032 (%)
    • 8.1.2. Prevention
    • 8.1.3. Active Infection Treatment
    • 8.1.4. Post-Infection Management

9. Infectious Wound Care Management Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Ambulatory Surgical Centers (ASCs)
    • 9.1.5. Home Healthcare

10. Infectious Wound Care Management Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Infectious Wound Care Management Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Infectious Wound Care Management Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Infectious Wound Care Management Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Infectious Wound Care Management Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Infectious Wound Care Management Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment Stage, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Infectious Wound Care Management Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. 3M Company
    • 11.2.2. Acelity (KCI Licensing, Inc.)
    • 11.2.3. Advanced BioHealing Inc.
    • 11.2.4. Aspen Surgical Products
    • 11.2.5. B. Braun Melsungen AG
    • 11.2.6. Baxter International Inc.
    • 11.2.7. Coloplast A/S
    • 11.2.8. ConvaTec Group PLC
    • 11.2.9. Derma Sciences, Inc.
    • 11.2.10. Hollister Incorporated
    • 11.2.11. Integra LifeSciences Corporation
    • 11.2.12. Medline Industries, LP
    • 11.2.13. Molnlycke Health Care AB
    • 11.2.14. Organogenesis Inc.
    • 11.2.15. Smith & Nephew plc
    • 11.2.16. Stryker Corporation
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제